In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...
As flu season approaches, local health officials are urging older adults to look into a newly approved, highly effective ...
The fate of the mRNA flu shot had been in doubt due to the Trump administration's hostility toward mRNA vaccines in the wake of the pandemic, with the FDA initially refusing to consider the vaccine.
The Food and Drug Administration has approved the first-ever mRNA flu vaccine, a shot that will use new technology to target evolving viruses and streamline vaccine production faster than traditional ...
On August 5, 2026, Moderna announced that the U.S. Food and Drug Administration (FDA) approved mFLUSIVA® (mRNA-1010), a seasonal influenza vaccine ...
Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 ...
Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. speaks as President Donald Trump listens at an event to promote his ...
Raina Biosciences Inc. (Raina), an mRNA technology and therapeutics company, has released data from its generative AI platform in Science. The data supports Raina's pioneering approach to mRNA design ...
Add Yahoo as a preferred source to see more of our stories on Google. The United States is turning its back on what could be the greatest medical advance in a generation — vaccines made with messenger ...
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results